Posts Tagged ‘today-announced’
Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results (PR Newswire via Yahoo! Finance)
17 Mar 2010Champions Biotechnology, Inc. , a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the third  fiscal quarter ended January 31, 2010.  Full details of Company’s financial results are available in the Company’s Form 10-Q at www.championsbiotechnology.com …
BioTime, Inc.
… f our fast growing population and standard of living are being tapped by biotechnology….Biotechnology hand in hand with genetic engineering will likely dominate the Green Revolution of this century – the fourth since Neolithic time….Today agribusiness and biotechnology are corporate terms that are difficult to translate on the village level and by small entrepreneurs….
Boston Scientific sinks on FDA review foulup Shares of Boston Scientific fell sharply Monday after the biotechnology….
1. Introduction Agricultural development over years has been the result of continuous agri skill
LEXINGTON, Mass.—-Cubist Pharmaceuticals, Inc. today announced that its President and CEO Michael Bonney will be honored with the second annual Massachusetts Biotechnology Council Innovative Leadership Award.
SALT LAKE CITY, UT–(Marketwire – March 10, 2010) – Green Star Products, Inc. (PINKSHEETS: GSPI) and its Consortium today announced that it will be auctioning.
SALT LAKE CITY, UT–(Marketwire – March 10, 2010) – Green Star Products, Inc. ( PINKSHEETS : GSPI ) and its Consortium today announced that it will be auctioning the United States licensing rights to a game changing proprietary algae growth biotechnology on September 9, 2010. Presently, the algae industry is being kept from commercialization because of its inability to produce enough biomass …
Biotechnology company Cytokinetics Inc. said Wednesday regulators have granted “orphan drug” status to its potential Lou Gehrig’s disease treatment.
NDIANAPOLIS, March 2 — PDS Biotechnology Corporation today announced that the company has been awarded a $1.28M phase 2 SBIR contract by the National Cancer Institute division of the US National Institutes of Health. …
About Biolexis
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.
Biotech
Categories
- Biotechnology News (1306)
Archives
- How to Train your Brain to keep you healthy and happy
- What makes you unique? Not genes so much as surrounding sequences, study finds
- How to Choose the Correct Workbenches For Your Organization’s Needs
- http://f-cup-products.blogspot.com/2010/03/puera-panic-sos-405mg-x-15-tablets-38.html
- A First: Microchips in living cells
- Enzyme Handbook: Volume 14: Class 2.7 – 2.8 Transferases EC 2.7.105 – EC 2.8.3.14
- Class 2 Transferases X: EC 2.7.1.113 – 2.7.5.7
- Seth Klarman’s Baupost Group Wins Big With Facet Biotech (FACT), Sells Some Shares
- The truth about health insurance profits
- Breaking down a three-tiered option play on the biotechnology concern (Schaeffers Research)
